The National Multiple Sclerosis Society aspires to bring the global community together to cure MS for everyone, aiming to achieve this goal as swiftly as possible. Their mission involves coordinating and focusing worldwide resources on essential research questions to accelerate progress toward ending MS.
The grant program supports research aligned with the Pathways to Cures Roadmap, focusing on STOPPING MS, RESTORING function, and ENDING MS through prevention. It prioritizes research worldwide across various approaches, including laboratory models, human studies, and population-based methods. The program values interdisciplinary collaboration, data sharing, and addressing the needs of underserved and understudied ethnic and racial populations in MS research. Additionally, it funds commercial R&D, including proof of concept studies, target engagement research, medicinal chemistry, PK/ADMET studies, and IND-enabling activities such as toxicology and compound scale-up.